Reduction in the utilization of prednisone or methotrexate in Canadian claims data following initiation of etanercept in pediatric patients with juvenile idiopathic arthritis
In adult patients with arthritis, use of the tumor necrosis factor (TNF) inhibitor etanercept (ETN) is often associated with a reduction in the utilization of co-medications, particularly steroids. Comparative...
Source: Pediatric Rheumatology - Category: Rheumatology Authors: Majed Khraishi, Brad Millson, John Woolcott, Heather Jones, Lisa Marshall and Nicolino Ruperto Tags: Research article Source Type: research
More News: Arthritis | Canada Health | Enbrel | Methotrexate | Pediatrics | Prednisone | Rheumatology